CLINICAL_TRIALS
research
· 2025-10-10
Clinical Trial Update: PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
Summary
PRISM is a recruiting study evaluating PSMA PET/MRI imaging after high-intensity focused ultrasound to detect recurrence of prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NYU Langone Health | Conditions: Prostate Cancer | Status: RECRUITING